Nationwide alert in China for the faulty rabies vaccine

The second largest drug manufacturing company “ Changchun Changsheng Life Sciences” were found guilty for violated national standards including usage of expired fluids and falsified production dates to produce rabies vaccine. Rabies Vaccines manufactured in China was widely exported to countries including India too.

This recent scandal of faulty Rabies Vaccines creating panic and especially in China. After taking a quick action on this, country has started a nationwide campaign to provide health consultation and free inoculation of rabies vaccines.

In India, the Drug Controller General of India also ordered immediately to withdraw rabies vaccines from the market and also banned their imports from Changchun Changsheng Life Sciences.

Healthcare centers, institutions and disease control centers have started providing consultation services for those who received or used rabies vaccines made by the company. 36,482 hospitals and health centers are designated by the China government to provide consultation. No life loss has been reported yet from the patients who injected with the faulty Rabies vaccines.

According to the report, Changchun Changsheng making use of expired fluids and false production dates is in continuity since April 2014 and had violated rules on production management and national drug standards for the vaccines.

China National Health Commission and the State Drug Administration are actively working on the issue and created an inoculation plan for patients who have injected rabies vaccines from the Changchun Changsheng company. And the patients who are getting treated and those whose required course are not yet completed can switch to vaccines from other companies at no charge.

China government also start giving free re-inoculated who have completed their courses less than a year ago and vaccination institutions will provide tracking, observation, and advisory services.

Related Posts

  • Pharma
  • July 9, 2025
  • 99 views
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The…

  • Pharma
  • July 9, 2025
  • 109 views
Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

That half-empty bottle of painkillers or expired anxiety pills in your drawer could do more harm than good and Apex drug regulatory body, CDSCO, has said it’s best to flush…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

HC-ordered expert panel for weight loss drug may be set up by mid-July

HC-ordered expert panel for weight loss drug may be set up by mid-July